---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-062595"
form_type: "8-K"
ticker: "BCLI"
cik: "0001137883"
company_name: "BRAINSTORM CELL THERAPEUTICS INC."
filed_at: "2025-06-25T23:59:59+00:00"
generated_at: "2026-05-18T18:59:29.945079+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Brainstorm Cell shareholders approve 2M share increase in equity plan pool

## Summary
- Shareholders approved increasing the shared pool under the 2014 plans by 2M shares, to 2,906,666 shares.
- Vote: 758,668 for, 362,809 against, 2,556,446 broker non-votes for the plan amendments.
- All seven director nominees elected; Dr. Stacy Lindborg received the most votes (1,055,967 for).
- Ratification of Brightman Almagor Zohar & Co. as FY2025 auditor approved (3,346,891 for).
- Approval of warrant share issuance under Nasdaq Rule 5635(d) passed (874,965 for).

## SEC filing metadata
- accession: 0001104659-25-062595
- form_type: 8-K
- ticker: BCLI
- cik: 0001137883
- company_name: BRAINSTORM CELL THERAPEUTICS INC.
- filed_at: 2025-06-25T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1137883/000110465925062595/0001104659-25-062595-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1137883/000110465925062595/tm2518995d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-062595
- JSON: https://secwatch.observer/filing/0001104659-25-062595.json
- Plain text: https://secwatch.observer/filing/0001104659-25-062595.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.